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Abstract The auxiliary a2d subunits of voltage-gated calcium channels are extracellular
membrane-associated proteins, which are post-translationally cleaved into disulfide-linked
polypeptides a2 and d. We now show, using a2d constructs containing artificial cleavage sites, that
this processing is an essential step permitting voltage-dependent activation of plasma membrane
N-type (CaV2.2) calcium channels. Indeed, uncleaved a2d inhibits native calcium currents in
mammalian neurons. By inducing acute cell-surface proteolytic cleavage of a2d, voltage-dependent
activation of channels is promoted, independent from the trafficking role of a2d. Uncleaved a2d
does not support trafficking of CaV2.2 channel complexes into neuronal processes, and inhibits
Ca2+ entry into synaptic boutons, and we can reverse this by controlled intracellular proteolytic
cleavage. We propose a model whereby uncleaved a2d subunits maintain immature calcium
channels in an inhibited state. Proteolytic processing of a2d then permits voltage-dependent
activation of the channels, acting as a checkpoint allowing trafficking only of mature calcium
channel complexes into neuronal processes.
DOI: 10.7554/eLife.21143.001
Introduction
The a2d subunits of voltage-gated calcium channels (CaV) have been identified to be key proteins in
synaptic function and synaptogenesis (Dickman et al., 2008; Kurshan et al., 2009; Hoppa et al.,
2012; Eroglu et al., 2009; Saheki and Bargmann, 2009). Therefore an understanding of their basic
mechanism(s) of action is of paramount importance. Although CaVa1 subunits form the pore and
determine the main functional and pharmacological attributes of the channels (Catterall, 2000), the
CaV1 and CaV2 channels are associated with auxiliary b and a2d subunits (Flockerzi et al., 1986;
Witcher et al., 1993; Takahashi et al., 1987; Liu et al., 1996). The a2d subunits increase CaV cur-
rents by a mechanism that is less well understood than that of the b subunits, which have a chaper-
one function (Van Petegem et al., 2004; Buraei and Yang, 2010; Dolphin, 2012; Zamponi et al.,
2015). The topology of the a2d proteins was initially determined for skeletal muscle a2d-1, but is
likely to generalize for all a2d subunits (Brickley et al., 1995; Gurnett et al., 1996, 1997). A single
gene encodes each a2d protein, which undergoes several post-translational processing steps, includ-
ing proteolytic cleavage into disulfide-linked a2 and d (Davies et al., 2010; Jay et al., 1991;
Ellis et al., 1988; De Jongh et al., 1990). Both a2 and d have been shown previously to be impor-
tant for the function of a2d-1 to increase CaV currents and influence the biophysical properties of the
currents (Gurnett et al., 1996, 1997). The structure of the skeletal muscle CaV1.1 complex has
recently been determined at 3.6 A˚ by cryo-electron microscopy (Wu et al., 2016). It shows
the interaction of the a2d-1 with several extracellular linkers in Domains I-III of CaV1.1. In particular
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the metal ion adhesion site (MIDAS) motif of the von Willebrand factor-A (VWA) domain interacts
with the extracellular loop between transmembrane segments 1 and 2 in Domain I.
Regarding the mechanism of action of a2d subunits, we have recently shown that a2d-1 increases
the density of CaV2.2 channels inserted into the plasma membrane by about two-fold in undifferenti-
ated neuro2A (N2A) cells (Cassidy et al., 2014); however the increase in currents directly attribut-
able to a2d-1 is much greater than this (Hoppa et al., 2012). In the present study, we therefore
examined whether there was an additional step responsible for promoting CaV2.2 calcium current
function by a2d subunits, in addition to their demonstrated effect on calcium channel trafficking
(Cassidy et al., 2014). We have specifically tested the hypothesis that this step involves the proteo-
lytic processing of a2d-1. Our results show that proteolytic maturation of a2d subunits is not only a
prerequisite for voltage-dependent activation of calcium channels, but is also an essential checkpoint
for trafficking of these mature calcium channels into neuronal processes.
Results
Mutation of six amino acids flanking the cleavage site in a2d-1 prevents
proteolytic processing of a2d-1 into a2 and d
We identified the proteolytic cleavage site in rat a2d-1 to be between A and V in the sequence
LEA//VEM, by homology with the published data in rabbit (Jay et al., 1991; De Jongh et al., 1990)
(Figure 1a,b). This sequence is strongly conserved in mammals (Figure 1—figure supplement 1).
We initially manipulated the cleavage site in a2d-1 (Figure 1b), in order to determine the extent of
mutation required across this site required to completely prevent proteolytic processing. Transient
expression in cell lines of wild type (WT) a2d-1 resulted in only partial cleavage into a2 and d subu-
nits, clearly observed only following deglycosylation (Figure 1c, lanes 1 and 3), compared to the
complete proteolytic cleavage observed in brain (Figure 1c, lanes 2 and 4). Replacing LEAVEM in
a2d-1 with a hexavaline (V6) sequence (Figure 1b) completely prevented its proteolytic processing,
as shown by the absence of cleaved a2-1 on reducing gels of whole cell lysate (WCL) (Figure 1d).
More conservative mutations did not effectively prevent the cleavage (data not shown). However,
we found that the lack of proteolytic cleavage did not affect the ability of a2(V6)d-1 to bind
3H-gaba-
pentin (Figure 1e). Furthermore, the a2(V6)d-1, like wild-type (WT) a2d-1, was found to be concen-
trated in detergent-resistant membranes (DRMs; Figure 1—figure supplement 2), and the KD for
3H-gabapentin binding in DRMs was unchanged, being 76.2 ± 7.8 nM for WT a2d-1 and 85.0 ± 13.7
nM for a2(V6)d-1 (Figure 1e), indicating that the uncleaved pro-form of a2d-1 is likely to be correctly
folded.
Prevention of proteolytic processing does not impair trafficking of
a2d-1 to the plasma membrane
We then decided to control the proteolytic processing of a2d-1 by inserting a Human Rhinovirus
(HRV) 3C-protease site (Cordingley et al., 1990) into a2d-1, in place of the endogenous cleavage
motif, to form a2(3C)d-1 (Figure 1b). This substitution completely prevented its proteolytic cleavage
(Figure 1f). However, a2(3C)d-1 was still expressed on the cell surface (Figure 1f–i) and in DRMs
(Figure 1—figure supplement 3), at similar levels to WT a2d-1.
We have previously shown that the amount of proteolytically-processed a2d-1 is increased on the
cell surface compared to the WCL in transfected tsA-201 cells (Kadurin et al., 2012). However, the
present results show that this processing of a2d-1 is not essential for its trafficking to the plasma
membrane.
Prevention of proteolytic processing of a2d-1 abolishes CaV2.2 current
enhancement
It has previously been established that co-expression of WT a2d-1 results in an enhancement of
CaV2.2/b1b currents in heterologous systems (for review see [Dolphin, 2012]). We could confirm this
result using b1b-GFP to ensure that all cells examined contain b1b; WT a2d-1 produced an 8.6-fold
increase of CaV2.2/b1b currents at +10 mV (Figure 2a,b). Strikingly, no increase was observed when
a2(3C)d-1 was co-expressed with CaV2.2/b1b (Figure 2a,b; Figure 2—figure supplement 1). This is
in contrast to the ability of a2(3C)d-1 to reach the plasma membrane itself. In agreement with this,
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Figure 1. Effect of mutation of a2d-1 to disrupt the proteolytic cleavage site. (a) Cartoon of uncleaved pro-a2d-1 and cleaved a2d-1, showing
the approximate position of inserted HA tag and disulfide bonds between a2 (grey) and d (blue). (b) Rat a2d-1 sequence at the identified cleavage-site.
The underlined sequence (including LEA//VEM) in a2d-1 was mutated to a V6 or 3C-protease motif. (c) Comparison of glycosylated (lanes 1, 2) and
deglycosylated a2d-1 (lanes 3, 4), expressed in tsA-201 cells (lanes 1, 3) or present in the brain (lanes 2, 4), showing resolution between pro-a2d-1 and
Figure 1 continued on next page
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another uncleavable construct used, a2(V6)d-1, was also unable to increase CaV2.2 currents (Fig-
ure 2—figure supplement 2).
Proteolytic processing of a2d-1 is not required for the interaction with
CaV2.2, and trafficking of the complex to the plasma membrane in cell
lines
We next examined whether a2(3C)d-1 is impaired in its interaction with CaV2.2, which would explain
its inability to increase CaV2.2 currents. However, we found that CaV2.2 co-immunoprecipitates with
a2(3C)d-1 to the same extent as WT a2d-1 (Figure 2c). Furthermore, using extracellularly-tagged
CaV2.2 to quantify the channels inserted into the plasma membrane (Cassidy et al., 2014), we found
that in undifferentiated N2A cells, the uncleaved a2(3C)d-1 remains capable of increasing the cell
surface density of CaV2.2 channels (123% increase compared to CaV2.2/b1b alone), by a similar
extent to WT a2d-1 (140% increase; Figure 2d,e). a2(3C)d-1 also increased cell surface expression of
CaV2.2 in the tsA-201 cells used for electrophysiology (Figure 2—figure supplement 3). We then
asked whether the depolarized resting membrane potential of N2A cells might influence their ability
to traffic CaV2.2. We therefore co-expressed the leak K
+ channel, TASK3 (Kim et al., 2000), to
hyperpolarize their membrane potential (Figure 2f), in order to determine whether this would differ-
entially affect CaV2.2 trafficking supported by WT a2d-1 and a2(3C)d-1. This was not the case, as a
similar increase in CaV2.2 surface expression was observed in the presence of TASK3 for CaV2.2,
with either WT a2d-1 or a2(3C)d-1 (Figure 2g).
Thus, when heterologously expressed in cell lines, a2(3C)d-1 cause an increase of CaV2.2 surface
expression, but does not result in an increase of CaV2.2 currents (see cartoon in Figure 2h), strongly
suggesting a2(3C)d-1 may play an inhibitory role on CaV2.2 function.
Proteolytic processing of a2d-1 is essential for voltage-dependent
activation of CaV2.2 Currents
In order to determine whether a2(3C)d-1 could be cleaved at the inserted 3C-protease site, we then
co-expressed an ER-lumen-targeted 3C-protease together with a2(3C)d-1 (Figure 3a). This resulted
in efficient proteolytic cleavage of a2(3C)d-1 into a2 and d, as shown by the appearance of a band of
the size of the a2 moiety, which reached the cell surface (Figure 3b; Figure 3—figure supplement
1a). As expected, co-expression of an inactive form of 3C-protease with a mutation in the catalytic
site (C147V) failed to affect a2(3C)d-1 (Figure 3—figure supplement 1b).
Next we addressed the important question of whether proteolytic cleavage by 3C-protease could
restore the currents through CaV2.2 channels containing a2(3C)d-1 subunits. In order to do this, we
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the cleaved form of a2d after deglycosylation. a2d* indicates glycosylated species, and pro-a2d and a2 indicate deglycosylated proteins. Uncleaved pro-
a2d-1 is observed in transfected cells, but not brain. Proteins visualized with a2-1 Ab. (d) a2d-1-HA (left) and a2(V6)d-1-HA (right) expressed in tsA-201
cells; proteins deglycosylated with PNGase-F. Upper panel: HA-blots, lower panel: endogenous GAPDH loading control. (e) Normalized binding curves,
using DRM fractions from transfected tsA-201 cells, for 3H-gabapentin binding to WT a2d-1 (&, n = 4) and a2(V6)d-1 (○, n = 4). Mean (± SEM) data are fit
by hyperbolae with KD of 82.3 and 68.3 nM, respectively. (f) Imunoblot analysis of deglycosylated a2d-1-HA and a2(3C)d-1-HA. WCL input (lanes 1, 2)
and cell-surface biotinylated material (lanes 3, 4) are shown. Upper panel: HA-blot, lower panel: endogenous GAPDH. (g) Mean ± SEM (and individual
data points) of a2(3C)d-1 (blue) cell surface levels, measured as a proportion of biotinylated: total protein, normalized to control (WT a2d-1; red), for 4
experiments including that shown in (f). p=0.5057, one sample t test. (h) Cell-surface expression of a2d-1-HA (left) and a2(3C)d-1-HA (right) in non-
permeabilized tsA-201 cells, using HA Ab (red). Nuclei visualized with DAPI (blue). Scale bars 20 mm. (i) Box and whisker plots for quantification of a2d-1
on cell-surface, from HA fluorescence, for experiments including (h), for WT a2d-1 (red) and a2(3C)d-1 (blue). N = 290 and 317 cells, respectively, from 3
separate transfections, normalized to WT a2d-1 in each experiment. p=0.259, Student’s t test.
DOI: 10.7554/eLife.21143.002
The following figure supplements are available for figure 1:
Figure supplement 1. Alignment of the proteolytic cleavage site in a2d-1, showing species conservation.
DOI: 10.7554/eLife.21143.003
Figure supplement 2. a2(V6)d-1 is localised in DRMs to a similar extent to a2d-1.
DOI: 10.7554/eLife.21143.004
Figure supplement 3. a2(3C)d-1 is localised in DRMs to a similar extent to a2d-1.
DOI: 10.7554/eLife.21143.005
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Figure 2. Effect of mutation of a2d-1 cleavage site to an HRV-3C site on cell-surface expression and functional properties of CaV2.2. (a) Example traces
( 30 to +10 mV in 5 mV steps) for CaV2.2/b1b-GFP and no a2d (black traces), WT a2d-1 (red traces) or a2(3C)d-1 (blue traces). Charge carrier 1 mM
Ba2+. Scale bars refer to all traces. (b) Mean (± SEM) IV curves for CaV2.2/b1b-GFP and no a2d (black open circles, n = 14), WT a2d-1 (red squares, n =
34) or a2(3C)d-1 (blue triangles, n = 21). Gmax: 0.25 ± 0.04, 1.91 ± 0.30 and 0.20 ± 0.03 nS/pF, respectively. V50,act: 2.85 ± 0.68, 3.33 ± 0.46 and 3.89 ± 0.53
Figure 2 continued on next page
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co-expressed 3C-protease with CaV2.2/b1b/a2(3C)d-1, and found that a2d-1-mediated CaV2.2 cur-
rent enhancement was robustly rescued by the active protease, whereas the inactive mutant 3C-pro-
tease (C147V) had no effect (Figure 3c–e). This was not accompanied by any change in CaV2.2
trafficking (Figure 3f,g). The peak IBa increase due to the 3C-protease was 5.4-fold at +10 mV, com-
pared to inactive protease (Figure 3c,d). Co-expression of 3C-protease with a2(3C)d-1 also resulted
in an increased activation rate of the CaV2.2 currents, to the same extent as WT a2d-1 (Figure 3e).
As expected, when a2(3C)d-1 was not present, there was no increase in CaV2.2 currents attributable
to 3C-protease (Figure 3—figure supplement 2).
In summary, expression of active, but not the inactive form of 3C-protease results in cleavage of
a2(3C)d-1 and rescues enhancement of CaV2.2 currents by a2(3C)d-1, without any effect on traffick-
ing, providing evidence that proteolytic processing of a2d-1 is required to promote voltage-depen-
dent activation CaV2.2 channels.
Replacement of the endogenous proteolytic site in WT a2d-3 with a 3C-
protease site allows controlled processing of a2d-3 to rescue CaV2.2
currents
In order to further distinguish between the effects of a2d subunits on CaV2.2 channel trafficking and
voltage-dependent activation, we also examined the behavior of a2d-3, because we surmised it
might have a less prominent trafficking effect, as it contains an incomplete MIDAS motif
(Whittaker and Hynes, 2002) in its VWA domain, which we have shown is essential for the traffick-
ing and function of a2d-1 and a2d-2 (Hoppa et al., 2012; Cassidy et al., 2014; Canti et al., 2005).
Indeed, we found that a2d-3 produced a much smaller increase than a2d-1 (31%, compared
to ~140%) on CaV2.2 cell surface expression (Figure 4a,b), which we attribute to the absence of a
complete MIDAS motif in a2d-3 (Whittaker and Hynes, 2002).
The site of proteolytic cleavage in a2d-3 has not been previously determined, although it is fully
cleaved into a2 and d in vivo (Davies et al., 2010), and enhances CaV2.2 currents (Davies et al.,
2010). We therefore first identified a potential cleavage site in a2d-3 by sequence alignment
(Figure 4c), and then showed by mutational analysis that a V6 mutation across the predicted cleav-
age site prevented proteolytic cleavage, determined by the appearance of the d-3 moiety in a reduc-
ing gel (Figure 4—figure supplement 1), and also prevented the functional effects of a2d-3 on
CaV2.2 currents (data not shown). We then replaced this sequence in a2d-3 with the HRV-3C motif,
to form a2(3C)d-3 (Figure 4c). We found that a2(3C)d-3 was expressed on the cell surface to a similar
extent to WT a2d-3 (Figure 4d), despite the complete absence of proteolytic cleavage (Figure 4d,
Figure 2 continued
mV, respectively. (c) tsA-201 cells transfected with GFP-CaV2.2 (lanes 1 and 3) or GFP (lanes 2 and 4), plus b1b, and either WT a2d-1 (lanes 1 and 2) or
a2(3C)d-1 (lanes 3 and 4). Immunoprecipitation of GFP-CaV2.2 with anti-GFP Ab; WB with CaV2.2 II-III loop Ab (upper panels, lanes 1 and 3) produced
co-immunoprecipitation (lower panels) of WT a2d-1 (lane 1) and a2(3C)d-1 (lane 3), revealed by a2d-1 mAb. Right panels: WCL input for lanes 1–4: upper
panels, CaV2.2-GFP input; lower panels, a2d-1 input. All samples deglycosylated. (d) Immunocytochemical detection of cell-surface expression of
CaV2.2-BBS, with b1b, and empty vector (left), WT a2d-1-HA (middle) or a2(3C)d-1-HA (right) in N2A cells. Upper panel: CaV2.2-BBS cell-surface staining
prior to permeabilization (grey-scale); lower panel: total CaV2.2 after permeabilization (II-III loop Ab, red). Scale bar 5 mm. (e) Quantification of CaV2.2-
BBS cell-surface expression (box and whisker plots) with empty vector (open bar, n = 206), WT a2d-1 (red bar, n = 191) or a2(3C)d-1 (blue bar, n = 181).
Statistical differences: ANOVA and Bonferroni post-hoc test; ***p<0.001, compared to no a2d. (f) Resting membrane potential of control N2A cells
(white bar, n = 16) and following expression of TASK3 (gray bar, n = 12). Box and whisker plots; ***p<0.0001, Student’s t test. (g) Quantification of
CaV2.2-BBS cell-surface expression in N2A cells co-expressing TASK3, with empty vector (gray bar, n = 70), WT a2d-1 (pink bar, n = 73) or a2(3C)d-1
(pale blue bar, n = 81). Box and whisker plots, statistical differences: ANOVA and Bonferroni post-hoc test, compared to no a2d; ***p<0.001. (h)
Cartoon showing the ability of ‘latent’ CaV2.2 (cyan) plus a2(3C)d-1 (grey a2, blue d), to traffic to the plasma membrane (PM).
DOI: 10.7554/eLife.21143.006
The following figure supplements are available for figure 2:
Figure supplement 1. Examination of effect of a2(3C)d-1 on CaV2.2/b1b calcium channel currents in tsA-201 cells.
DOI: 10.7554/eLife.21143.007
Figure supplement 2. Examination of effect of a2(V6)d-1 on CaV2.2/b1b calcium channel currents in tsA-201 cells.
DOI: 10.7554/eLife.21143.008
Figure supplement 3. Examination of effect of a2(3C)d-1 on CaV2.2/b1b cell surface expression in tsA-201 cells.
DOI: 10.7554/eLife.21143.009
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Figure 3. Effect of proteolytic cleavage of a2d-1 containing an HRV-3C cleavage site on cell-surface expression and functional properties of CaV2.2. (a)
Cartoon showing intracellular cleavage by 3C-protease (green) of a2(3C)d-1 (gray/blue) associated with CaV2.2 (cyan). (b) Deglycosylated, cell-surface
biotinylated fractions for a2d-1-HA (lanes 1 and 2) and a2(3C)d-1-HA (lanes 3 and 4), expressed in tsA-201 cells without (lanes 1 and 3) or with (lanes 2
and 4) 3C-protease. Representative of n = 4 experiments. WCL in Figure 3—figure supplement 1 (c) Example traces ( 30 to +10 mV steps) for CaV2.2/
Figure 3 continued on next page
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lane 3). Importantly, when the 3C-protease was co-expressed, we found that a2(3C)d-3 was still pres-
ent on the cell surface, and was almost completely cleaved at the inserted HRV-3C site (Figure 4d,
lane 4), although this had no effect on WT a2d-3 (Figure 4d,e; Figure 4—figure supplement 2a,b).
As we also found for a2(3C)d-1, a2(3C)d-3 did not increase CaV2.2 currents, whereas WT a2d-3 pro-
duced a 6.6-fold increase (Figure 4f). However, inducing proteolytic cleavage of a2(3C)d-3 by 3C-
protease substantially rescued the enhancement of CaV2.2 currents, whereas the mutant protease
3C (C147V) did not (Figure 4g,h). The increase in peak IBa due to the 3C protease was 2.7-fold
at +10 mV, compared to inactive protease.
In summary WT a2d-3 has a much smaller effect on CaV2.2 cell surface trafficking than WT a2d-1,
but proteolytic cleavage of a2(3C)d-3 still produces a substantial increase in CaV2.2 currents.
Proteolytic processing of a2d subunits on the cell surface leads to
rescue of CaV2.2 Currents
In order to further probe the role of proteolytic processing of the a2d subunits on calcium channel
currents, independent of their trafficking effects, we next turned to application of extracellular prote-
ase. However, we found that incubation of cells expressing a2(3C)d-1 or a2(3C)d-3 with purified 3C-
protease did not result in their proteolytic cleavage at the plasma membrane (Figure 4—figure sup-
plement 3, and data not shown). As an alternative approach, we inserted a thrombin cleavage site
into a2d-3 to produce a2(Th)d-3 (Figure 5a,b). Importantly, we first showed that extracellular throm-
bin did not cleave WT a2d-3 (Figure 5—figure supplement 1), and we found that a2(Th)d-3 reached
the cell surface as an uncleaved protein (Figure 5c,d; Figure 5—figure supplement 1). Furthermore,
application of thrombin in the extracellular medium then produced marked cleavage of a2(Th)d-3 on
the cell surface (Figure 5c), and the optimal incubation period was about 60 min (Figure 5—figure
supplement 1). This experiment was not attempted for a2d-1 as preliminary studies revealed that
a2d-1 contained an ectopic thrombin cleavage site (data not shown).
In line with previous results, uncleaved a2(Th)d-3 failed to mediate CaV2.2 current enhancement
(Figure 5e). However, when thrombin was added to cells expressing CaV2.2/b1b and a2(Th)d-3, prior
to Ba2+ current recording, it resulted in an acute increase in IBa amplitude (Figure 5e–g), clearly
demonstrating that cleavage of a2(Th)d-3 has a direct effect to rescue CaV2.2/b1b/a2(Th)d-3 cur-
rents. In contrast, extracellular application of thrombin had no effect on CaV2.2/b1b/WT a2d-3 or
CaV2.2/b1b currents (Figure 5e–g). Therefore, the functional role of a2d-3 on CaV2.2 channels can
be acutely restored at the plasma membrane via specific proteolytic cleavage of extracellular
a2(Th)d-3.
Figure 3 continued
b1b-GFP/a2(3C)d-1-HA and no protease (black traces), 3C-protease (blue traces) or inactive mutant 3C-(C147V) protease (cyan traces). Charge carrier 1
mM Ba2+. Scale bars refer to all traces. (d) Mean (± SEM) IV curves for CaV2.2/b1b-GFP/a2(3C)d-1-HA and no protease (black open circles, n = 26), 3C-
protease (blue squares, n = 22) or 3C-(C147V)-protease (cyan triangles, n = 23). Gmax: 0.26 ± 0.04, 0.90 ± 0.22 and 0.22 ± 0.03 nS/pF, respectively. Gmax
values in the presence of the active 3C-protease were greater than in the absence of protease or presence of 3C-(C147V)-protease (Kruskal-Wallis test
with Dunn’s multiple comparison post-hoc test, p<0.05). V50,act: 6.05 ± 0.82, 5.18 ± 0.74 and 6.20 ± 1.20 mV, respectively. (e) Time constant of activation
(tact) for IBa at +10 mV for CaV2.2/b1b-GFP with no a2d-1 (open bar, n = 14), WT a2d-1-HA (red bar, n = 25), a2(3C)d-1-HA (blue bar, n = 21) or a2(3C)d-
1-HA + 3C-protease (blue hatched bar, n = 17). Box and whisker plots. Statistical significance determined by ANOVA and Bonferroni’s post-hoc test
(*p<0.05). (f) Immunocytochemical detection of cell-surface CaV2.2-BBS, plus b1b, and a2d-1-HA (left panel) or a2(3C)d-1-HA (right panel), with 3C-
protease. Upper panel: CaV2.2-BBS cell-surface staining (grey-scale), lower panel total CaV2.2 (II-III loop staining). Scale bar 5 mm. (g) Lack of effect of
3C-protease (hatched bars) on cell-surface expression of CaV2.2-BBS following expression of CaV2.2-BBS/b1b in N2A cells, with no a2d (open bar,
n = 206), WT a2d-1 (red bar, n = 212), WT a2d-1 and 3C-protease (red hatched bar, n = 192), a2(3C)d-1 (blue bar, n = 181) or a2(3C)d-1 and 3C-protease
(blue hatched bar, n = 200). Box and whisker plots. Statistical differences determined by ANOVA and Bonferroni’s post-hoc test (***p<0.001; ns:
p>0.05).
DOI: 10.7554/eLife.21143.010
The following figure supplements are available for figure 3:
Figure supplement 1. The effect of 3C-protease on a2d-1 and a2(3C)d-1 expressed in tsA-201 cells.
DOI: 10.7554/eLife.21143.011
Figure supplement 2. Lack of effect of 3C-protease on CaV2.2/b1b currents expressed in tsA-201 cells.
DOI: 10.7554/eLife.21143.012
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Figure 4. Effect of proteolytic cleavage of a2d-3 containing an HRV-3C cleavage site on cell-surface expression and functional properties of CaV2.2.
(a) Images showing cell-surface CaV2.2-BBS (upper row, white), and total CaV2.2 (II-III loop Ab, lower row, red), for CaV2.2-BBS/b1b in N2A cells, with
empty vector (panel 1) or a2d-3-HA (panel 2). Scale bar 5 mm. (b) Quantification (box and whisker plots) of effect a2d-3 on cell-surface CaV2.2-BBS
following expression of CaV2.2-BBS/b1b with empty vector (open bar, n = 188) or WT a2d-3 (red bar, n = 188). Statistical difference determined by
Figure 4 continued on next page
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Identification of the subcellular location of physiological cleavage of
a2d-1 subunits in DRG neurons
The a2d-1 protein is extensively up-regulated in DRG neurons, following experimental peripheral
nerve injury, such as spinal nerve ligation (SNL), and is trafficked to presynaptic terminals along the
axon in intracellular trafficking vesicles (Bauer et al., 2009). This up-regulation allowed us to obtain
sufficient protein to follow the processing of a2d-1. Following dissection of DRGs and associated
axons, we observed that a2d-1 was fully glycosylated in the cell bodies of the DRGs, but remained
only partially cleaved into a2 and d (Figure 6a, tissue segment 3). We have shown previously by elec-
tron microscopy that within the cell body, a2d-1 is present both in the endoplasmic reticulum and at
the plasma membrane, whereas in axons it is entirely associated with intracellular transport vesicles
(Bauer et al., 2009). In the axons, we observed that proteolytic cleavage of a2d-1 was complete,
both in the spinal nerve (Figure 6a, tissue segments 1, 2), and in the dorsal roots (Figure 6a, tissue
segments 4, 5). This finding implies that all a2d-1 is proteolytically processed prior to intracellular
trafficking into DRG axons. Indeed, our biochemical and cell fractionation data indicate that proteo-
lytic cleavage occurs mainly during trafficking to the plasma membrane (Kadurin et al., 2012) (data
not shown). However, this result opens the possibility that uncleaved a2d-1 may reach the cell sur-
face in DRGs cell bodies and have a functional role there.
We then expressed WT a2d-1 in cultured DRG neurons in order to mimic its upregulation in the
neuropathic state, and detected a significant amount of pro-a2d-1 in WCL (Figure 6b, lane 2). As
expected, transfection of a2(3C)d-1 into DRG neurons resulted in abundant expression of the pro-
a2(3C)d-1 form in WCL (Figure 6b, lane 3).
Uncleaved pro-a2d-1 plays an inhibitory role in the calcium channel
function
We then investigated whether uncleaved a2d-1 was inactive, or whether its presence might play an
inhibitory role, as suggested by the fact that a2(3C)d-1 increases cell surface expression of CaV2.2 by
about 2.5-fold in cell lines, but does not support any increase of CaV2.2 currents. We therefore
examined the effect of a2(3C)d-1 expressed in cultured DRG neurons on native calcium channel cur-
rents (Figure 6c). We have previously shown that expression of WT a2d-1 in cultured DRG neurons
caused an increase of native calcium currents (D’Arco et al., 2015) (shown with additional data in
Figure 6d). Here, we found that expression of a2(3C)d-1 produced a marked reduction in
Figure 4 continued
Student’s t test, **p=0.0028. (c) Alignment of a2d-3 sequence around the predicted cleavage site with a2d-1, showing weak homology. Underlined
sequence (MTAKAQ) mutated to V6 or HRV-3C cleavage motif. (d) a2d-3-HA (lanes 1, 2) and a2(3C)d-3-HA (lanes 3, 4) expressed in tsA-201 cells, with
either inactive (C147V, lanes 1, 3) or WT 3C-protease (WT, lanes 2, 4), cell-surface biotinylated and deglycosylated. Full WB and corresponding WCL in
Figure 4—figure supplement 3 (e) Quantification of cell-surface expression of WT a2d-3-HA (red speckled bar) and a2(3C)d-3-HA (blue speckled bar),
with 3C-protease, normalized relative to inactive 3C-protease (C147V) for n = 3 experiments. Data are mean (± SEM) and individual data points:
p=0.4721 for WT a2d-3-HA and p=0.9513 for a2(3C)d-3 (1 sample t-test compared to respective control). (f) Example traces ( 30 to +5 mV steps) for
CaV2.2/b1b-GFP with no a2d (black traces), WT a2d-3 (red traces) or a2(3C)d-3 (blue traces). Gmax: 0.24 ± 0.03, 1.46 ± 0.22 and 0.21 ± 0.03 nS/pF
respectively. V50,act: 0.91 ± 1.015, 1.01 ± 0.85 and 4.03 ± 1.04 mV, respectively. (g) Example traces ( 30 to +10 mV steps) for CaV2.2/b1b-GFP/a2(3C)d-3
and no protease (black traces), 3C-protease (blue traces) or inactive 3C-protease (C147V) (cyan traces). For (f) and (g), charge carrier 1 mM Ba2+, scale
bars refer to all traces. (h) Mean (± SEM) IV curves for CaV2.2/b1b-GFP/a2(3C)d-3 without protease (black open circles, n = 28), with 3C-protease (blue
squares, n = 29) or inactive 3C-(C147V)-protease (cyan triangles, n = 24). Gmax: 0.28 ± 0.05, 0.70 ± 0.11 and 0.30 ± 0.08 nS/pF, respectively. Gmax for 3C-
protease condition larger than other two conditions (Kruskal-Wallis test with Dunn’s post-hoc test, p<0.05). V50, act: 4.0 ± 0.7, 0.3 ± 0.7 and 1.5 ± 0.6 mV,
respectively.
DOI: 10.7554/eLife.21143.013
The following figure supplements are available for figure 4:
Figure supplement 1. Lack of cleavage of a2(V6)d-3.
DOI: 10.7554/eLife.21143.014
Figure supplement 2. Effect of 3C-protease on expression and cleavage of a2(3C)d-3.
DOI: 10.7554/eLife.21143.015
Figure supplement 3. Lack of effect of purified 3C-protease on expression and cleavage of a2(3C)d-3.
DOI: 10.7554/eLife.21143.016
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Figure 5. Effect of thrombin on the properties and function of a2d-3 containing a thrombin proteolytic cleavage site. (a) Sequence at a2d-3 cleavage
site mutated to a thrombin cleavage site. (b) Cartoon of thrombin cleavage of a2d-3 on cell-surface. (c) Cell-surface biotinylation (left panel) shows
efficient cleavage of cell-surface a2(Th)d-3-HA (lane 2), with no effect on total a2(Th)d-3-HA in WCL (right panel, lane 4). Samples were deglycosylated
prior to loading. (d) Quantification of cell surface biotinylation experiments such as those shown in (c), indicating that thrombin does not decrease the
Figure 5 continued on next page
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endogenous calcium channel currents in DRG neurons (by 43.2% at +10 mV; Figure 6c,d), support-
ing the hypothesis that pro-a2d-1 inhibits endogenous DRG calcium currents.
Furthermore, when CaV2.2-HA was transfected with b1b and WT a2d-1 into DRG neurons, there
was a clear increase in CaV2.2-HA on the cell surface of the DRG cell bodies after 2 days, compared
to CaV2.2-HA/b1b alone (Figure 6e,f). In contrast, for co-expression with a2(3C)d-1, the amount of
CaV2.2-HA on the plasma membrane was the same as without exogenous a2d, rather than showing
any inhibition (Figure 6e,f). This suggests that the inhibitory effect of a2(3C)d-1 on DRG calcium cur-
rents (Figure 6c,d) is not due to inhibition of channel trafficking to the somatic plasma membrane.
Proteolytic cleavage of a2d-1 is required for trafficking of CaV2.2 Into
neuronal processes
In view of our finding that all endogenous a2d-1 is proteolytically cleaved in axons but not cell bod-
ies (Figure 6a), we then asked whether proteolytic processing was required for trafficking either of
a2d-1 itself, or of associated CaV2.2, into neuronal processes. For this purpose, we used cultured hip-
pocampal neurons which can be transfected after the establishment of extensive neurite outgrowth
in culture. We found the surprising result that, when we co-transfected CaV2.2/b1b with either WT
a2d-1, a2(3C)d-1 or the corresponding empty vector, WT a2d-1 was essential for trafficking of CaV2.2
into the processes of hippocampal neurons, whereas in the presence of a2(3C)d-1, or without a2d,
there was virtually no trafficking of CaV2.2 out of the soma (Figure 7a,b). Strikingly, the inability of
a2(3C)d-1 to drive CaV2.2 into neuronal processes was reversed by co-expression of 3C-protease
(Figure 7c,d).
The failure of CaV2.2 to traffic into the neurites in the presence of a2(3C)d-1 was not primarily due
to a defect in the trafficking of the uncleaved a2d subunit itself, since, when the a2d subunits were
transfected alone, WT a2d-1 and a2(3C)d-1 were both able to extensively access the hippocampal
neurite compartment (Figure 7e,f). In contrast, when the localization of the a2d subunits was exam-
ined following co-transfection with CaV2.2/b1b, the trafficking of a2(3C)d-1 into neurites was 37%
lower than that of WT a2d-1 (Figure 7g,h), suggesting it has been retained by interaction with
CaV2.2. Similar results to those with a2d-1 were obtained when comparing the ability of WT a2d-3
and a2(3C)d-3 to traffic CaV2.2 into neurites, which was also reversed by 3C-protease (data not
shown). This further confirmed that the association of CaV2.2 with mature processed a2d subunits is
essential for trafficking of the complex into hippocampal neurites (Figure 7—figure supplement 1).
Proteolytic cleavage of a2(3C)d-1 enhances Ca
2+ entry into hippocampal
boutons
We then examined the effect of expression of a2(3C)d-1 alone in hippocampal neurons on action
potential (AP)-induced Ca2+ entry into presynaptic boutons. These were identified by co-expressed
vesicle-associated membrane protein-mOrange2 (VAMP-mOr2), and Ca2+ transients were measured
using synaptophysin-GCaMP6f (sy-GCaMP6f, Figure 8a). The uncleaved a2(3C)d-1 reduced Ca
2+
entry in response to single AP stimulation in all experiments performed (Figure 8b,c), to 65.8 ± 9.1%
Figure 5 continued
amount of a2(Th)d-3-HA on the cell surface (hatched blue bar), normalized to vehicle application in each experiment (solid blue bar). Mean (± SEM) and
individual data points for n = 4; p=0.2105, 1 sample t test. (e) Mean (± SEM) and individual data points of peak IBa at +10 mV, for CaV2.2/b1b with WT
a2d-3 (red squares), a2(Th)d-3 (blue triangles) or no a2d (black circles) and either no protease (closed symbols), or 60 min thrombin incubation (open
symbols). The charge carrier was 2 mM Ba2+. For data without or with thrombin, respectively, n = 12, 16 for WT a2d-3; 15, 24 for a2(Th)d-3 and 11, 7
without a2d, from at least 3 independent transfections. Statistical difference between thrombin and vehicle determined by Kruskal-Wallis ANOVA and
Dunn’s multiple comparison post-hoc test, *p<0.05. (f) Mean (± SEM) full IV curves for the same conditions as in (e) (excluding the no a2d data), fitted
with a modified Boltzmann equation to +50 mV. Gmax values (nS/pF) were 2.80 ± 0.61 (WT a2d-3; n = 10), 2.60 ± 0.55 (WT a2d-3 plus thrombin, n = 15),
0.43 ± 0.08 (a2(Th)d-3; n = 14), 1.26 ± 0.21 (a2(Th)d-3 plus thrombin, n = 21). V50,act values (mV) were +0.44 ± 1.71 (WT a2d-3), + 0.55 ± 1.28 (WT a2d-3
plus thrombin), +9.34 ± 0.08 (a2(Th)d-3), +0.87 ± 1.38 (a2(Th)d-3 plus thrombin). (g) Example Ba
2+ currents (from  50 to +60 mV) for the four conditions
shown in (f).
DOI: 10.7554/eLife.21143.017
The following figure supplement is available for figure 5:
Figure supplement 1. Controls for cleavage of a2(Th)d-3 by thrombin.
DOI: 10.7554/eLife.21143.018
Kadurin et al. eLife 2016;5:e21143. DOI: 10.7554/eLife.21143 12 of 26
Research article Biochemistry Neuroscience
Figure 6. Proteolytic processing of endogenous a2d-1 and effect of exogenous expression of a2d-1 and a2(3C)d-1 in DRGs. (a) DRGs, spinal nerves and
dorsal roots from rats, 4 days after SNL, were dissected and segmented according to the diagram. X marks site of ligation. Tissue was pooled from 4
rats. It was either treated or not with PNGase-F as indicated, and reduced with DTT; deglycosylation allows resolution of two a2-immunoreactive bands.
Unprocessed a2d-1 is present only in the cell body compartment (segment 3) and is distinct from processed a2-1 (indicated by arrows). Lower blot is
Figure 6 continued on next page
Kadurin et al. eLife 2016;5:e21143. DOI: 10.7554/eLife.21143 13 of 26
Research article Biochemistry Neuroscience
(n = 7, p=0.0093, 1 sample t test) of control. The inhibitory effect of a2(3C)d-1 on the response to a
single AP was reversed by co-expression of 3C-protease in all experiments performed (Figure 8d,e),
an increase of 81.5 ± 16.1% (n = 8, p<0.0001, 1 sample t test).
Discussion
In this study, we have identified key roles for proteolytic processing of pro-a2d subunits. Our main
findings are: firstly that proteolytic cleavage of pro-a2d represents an essential step for
the expression of mature functional calcium channels. Here we show, using a combination of techni-
ques, that the appearance of functional CaV2.2 channels associated with the proteolytic processing
of a2d subunits, occurs independently of changes in channel trafficking to the plasma membrane in
undifferentiated cell lines. A key experiment is the demonstration that acute restoration of voltage-
dependent activation by proteolytic cleavage of pro-a2d can be induced at the cell surface by extra-
cellularly applied protease. Secondly, we find that lack of proteolytic cleavage of a2d-1 represents a
very significant barrier to trafficking of CaV2.2 channels into cultured hippocampal neuronal pro-
cesses. Trafficking of the channel complex into neurites is dependent on an effect of mature cleaved
a2d on CaV2.2, rather than due primarily to the differential ability of mature a2d to be trafficked and
uncleaved pro-a2d to be retained in the soma. This is clearly shown by the fact that uncleaved
a2(3C)d-1 is fully able to traffic alone into neurites. Thirdly, we provide evidence for an inhibitory role
for the pro-form of a2d-1. It is highly likely that proteolytic cleavage of a2d could induce a conforma-
tional change, which would impact on its interaction with the a1subunit. The recent structure of the
CaV1.1 complex resolves the domain structure of the a2d-1 subunit to contain the VWA domain and
four tandem cache domains (Wu et al., 2016). The d subunit contributes part of the fourth cache
domain, and it is therefore possible that the domain organization would be modified by proteolytic
cleavage of a2d.
In a previous study, we showed that WT a2d-1 increases the amount of CaV2.2 on the cell surface
in N2A cells, by about two-fold (Cassidy et al., 2014). We have also found that heterologously-
expressed a2d subunits are only partially processed into a2 and d in all expression systems exam-
ined, although proteolytic cleavage was much more marked at the plasma membrane (Davies et al.,
2010; Kadurin et al., 2012). The incomplete cleavage of heterologously expressed WT a2d is in con-
trast to the complete processing of muscle and brain a2d-1 (Jay et al., 1991; Patel et al., 2013) and
cerebellar a2d-2 (Davies et al., 2006), and likely represents saturation of the processing enzyme(s).
Thus, it was clear that determining the role of proteolytic cleavage of a2d on calcium channel func-
tion would require additional strategies. A previous study found that various mutations around the
cleavage site reduced, but did not abolish, calcium current enhancement by a2d-1 subunits
(Andrade et al., 2007), leaving the role of proteolytic cleavage of a2d-1 an open question. Here we
show conclusively that for both a2d-1 and a2d-3, mutations that prevent their cleavage into a2 and d
do not prevent the appearance of pro-a2d on the cell surface. Furthermore, in the cell lines exam-
ined here, but not in neurons, CaV2.2 trafficking to the plasma membrane was enhanced by an
uncleaved pro-form of a2d-1 to a similar extent as for WT a2d-1, utilising a mechanism that is inde-
pendent of the plasma membrane potential. However, this led to the increased cell surface
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GAPDH loading control. (b) WCL for empty vector-transfected DRGs (U/T, lane 1); WT a2d-1-HA-transfected DRGs (lane 2); a2(3C)d-1-HA transfected
DRGs (lane 3). WB: anti-HA. (c) Left: Example traces ( 45 to +5 mV steps) for control (empty vector-transfected) DRG neurons (black traces, top) and
DRGs transfected with a2(3C)d-1 (blue traces, bottom). The charge carrier is 1 mM Ba
2+. The scale bars refer to all traces. Right: Mean (± SEM) IV curves
for control DRG neurons (black squares, n = 12) and DRGs transfected with a2(3C)d-1 (blue circles, n = 14), from 3 independent experiments. Gmax
values were 2.20 ± 0.30 and 1.26 ± 0.14 nS/pF, respectively; p=0.0061 (Student’s t test). V50, act values were  1.5 ± 1.2 and  1.5 ± 0.7 mV, respectively.
(d) Comparison of normalized peak IBa in control DRGs (open red bar, n = 55) and WT a2d-1-transfected DRGs (closed red bar, n = 54) including data
from Figure 2d in, or comparison of control DRGs (open blue bar, n = 12) with a2(3C)d-1 transfected DRGs (closed blue bar, n = 14). Box and whisker
plots. Statistical differences, Student’s t test: *, p=0.048, **p=0.0067 compared to respective control. (e) Confocal optical sections (1 mm) showing GFP-
CaV2.2-HA in non-permeabilized DRG neurons (top, white), when co-transfected with b1b and either empty vector (left), WT a2d-1 (middle) or a2(3C)d-1
(right). GFP fluorescence is shown in the merged lower panel. Scale bars: 10 mm. (f) Box and whisker plot of cell surface HA fluorescence density as a
ratio of internal GFP density for CaV2.2-HA expression in DRG somata, transfected with empty vector (open bar, n = 81), WT a2d-1 (red bar, n = 133) or
a2(3C)d-1 (blue bar, n = 159). ***p<0.001, 1 way ANOVA and Bonferroni post hoc test.
DOI: 10.7554/eLife.21143.019
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Figure 7. Effect of a2d-1 and proteolytic cleavage of a2(3C)d-1 on trafficking of CaV2.2 into hippocampal neurites. (a) Images showing CaV2.2-HA in
permeabilized hippocampal neurons (top, white), when co-transfected with b1b, mCherry (bottom, red) and either no a2d (left), WT a2d-1 (middle) or
a2(3C)d-1 (right). Scale bar: 50 mm applies to all images. (b) Box and whisker plots for CaV2.2-HA expression in processes without a2d (open bar, n = 136
processes from 29 cells), with a2d-1 (red bar, n = 147 processes from 27 cells) or with a2(3C)d-1 (blue bar, n = 109 processes from 22 cells). ***p<0.001,
Figure 7 continued on next page
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expression of a calcium channel complex which appeared to be non-functional, since the uncleaved
pro-a2d did not enhance CaV2.2 calcium currents. Thus trafficking of CaV2.2 to the plasma mem-
brane by a2d-1 subunits in cell lines can be uncoupled from the functional effects of a2d subunits on
voltage-dependent activation of the channels.
Previous in vitro studies have examined the effect of a2d subunits on calcium channel currents
resulting from several combinations of CaVa1 and b subunits. In whole-cell current recordings, a2d
subunits increase the maximum conductance from 3 to 10-fold, depending on subunit combination
and conditions used (Canti et al., 2005; Mori et al., 1991; Klugbauer et al., 1999; Hobom et al.,
2000; Gao et al., 2000; Barclay et al., 2001; Hendrich et al., 2008). However, they have no effect
on single channel conductance, and for CaV2 channels there are only minor effects of a2d subunits
on most parameters relating to open probability (Hoppa et al., 2012; Barclay et al., 2001;
Brodbeck et al., 2002; Wakamori et al., 1999; Meir and Dolphin, 1998), which would be unlikely
to account for the large increase in whole-cell conductance. By contrast, a finding that is consistent
with the increase in whole-cell current, is that the fraction of null traces was markedly reduced by
a2d-1 in unitary current recordings from oocytes expressing CaV2.2/b1b/a2d-1 (9% null traces), a 3–
4-fold decrease, compared with those expressing CaV2.2 alone (39% null traces) or CaV2.2/b1b (28%
null traces) (Wakamori et al., 1999). This observation suggests that a2d shifts the equilibrium
towards active modes of the channel, from an inactive null mode represented by the long closed
state. Furthermore, it has recently been shown that a2d-1 promotes voltage sensor movement of
CaV1.2 (Savalli et al., 2016), thus hyperpolarizing channel activation (Savalli et al., 2016). Although
the interaction of a2d subunits with CaV2 channels may differ, as there is not such a clear shift in
the voltage-dependence of activation (Kadurin et al., 2012; Canti et al., 2005), it is tempting to
speculate that the association of the channels with uncleaved pro-a2d might interfere with voltage
sensor movement.
We have found previously that the MIDAS motif in the VWA domains of a2d-1 and a2d-2 subunits
is key to increasing calcium channel function (Hoppa et al., 2012; Cassidy et al., 2014; Canti et al.,
2005). The recent structure of CaV1.1 indicates that the VWA domain MIDAS motif of a2d-1 closely
associates with the loop between S1 and S2 in Domain I of the a1S subunit (Wu et al., 2015). The
VWA domain is present in all a2d subunits, but it only has a perfect MIDAS motif in a2d-1 and a2d-2
(Dolphin, 2013). Thus a2d-3 has an incomplete MIDAS motif, which is predicted to have reduced
function (Whittaker and Hynes, 2002), and indeed a2d-3 has less effect on cell surface expression
of CaV2.2 than a2d-1 in the present study (compare Figures 2c and 4b).
In agreement with the hypothesis that pro-a2d is an inhibitory gate-keeper for calcium channel
function, we observed here that an uncleaved a2d-1 construct (a2(3C)d-1) had an inhibitory effect on
endogenous DRG neuron calcium currents, and on presynaptic Ca2+ entry in hippocampal neuronal
boutons, which could be reversed by co-expression of the 3C-protease. This is in contrast to a previ-
ous study in which overexpression of WT a2d subunits, which will form a mixture of both cleaved and
uncleaved a2d (Figure 6b), reduced Ca
2+ entry at synapses (Hoppa et al., 2012). Our result
Figure 7 continued
1 way ANOVA and Bonferroni post hoc test. (c) Images showing CaV2.2-HA in permeabilized hippocampal neurons (white), when co-transfected with
b1b, a2(3C)d-1 and mCherry (transfection marker, not shown), either without (left) or with (right) 3C-protease. Scale bar: 50 mm applies to both images.
(d) Box and whisker plots for CaV2.2-HA expression in processes with a2(3C)d-1, transfected without (solid blue bar, n = 191 processes), or with 3C-
protease (blue hatched bar, n = 187 processes). ***p<0.001, 1 way ANOVA and Bonferroni post hoc test. (e) Images showing WT a2d-1-HA (left) or
a2(3C)d-1-HA (right) expressed in permeabilized hippocampal neurons (white), co-transfected only with mCherry (transfection marker, not shown).
Antigen retrieval was used prior to the HA Ab. Scale bar: 50 mm applies to both images. (f) Box and whisker plots for expression in the processes of WT
a2d-1-HA (red bar, n = 248 processes from 52 cells) and a2(3C)d-1 (blue bar, n = 263 processes from 51 cells). (g) Images showing a2d-1 in hippocampal
neurons (white), when transfected with CaV2.2-HA, b1b, mCherry (transfection marker, not shown) and either WT a2d-1 (left) or a2(3C)d-1 (right). Antigen
retrieval was used prior to the a2d-1 mAb. Scale bar: 50 mm applies to both images. (h) Box and whisker plots for a2d-1 expression in hippocampal
processes, for WT a2d-1 (red bar, n = 221 processes) and a2(3C)d-1 (blue bar, n = 184 processes). ***p<0.0001, Student’s t test.
DOI: 10.7554/eLife.21143.020
The following figure supplement is available for figure 7:
Figure supplement 1. Cartoon showing processing and trafficking of a2d in neurons.
DOI: 10.7554/eLife.21143.021
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indicates that proteolytic processing of a2d-1 represents an essential functional checkpoint to allow
channel activation by depolarization, and the pro-a2d species inhibits function.
Furthermore, we show here that native pro-a2d-1 can be observed in the cell bodies of DRG neu-
rons, but in the axons it is completely processed to a2 and d; this is despite the fact that it is still
present in intracellular trafficking vesicles (Bauer et al., 2009). It is of interest in this regard that
although a2d-1 is elevated in all DRG neurons following nerve injury (Bauer et al., 2009; Luo et al.,
2001), calcium currents from DRGs extracted after nerve injury show a variable decrease in calcium
currents (Hogan et al., 2000; McCallum et al., 2006, 2011). This would agree with the present find-
ing that somatic DRG a2d-1 upregulated after nerve injury remains in part uncleaved, and that only
when in its mature processed form can it function to increase calcium currents and trafficking of cal-
cium channels into neurites.
The functional importance of proteolytic cleavage of a2d subunits is further emphasised by our
finding that the trafficking of CaV2.2 into the processes of cultured hippocampal neurons is
Figure 8. Effect of proteolytic cleavage of a2(3C)d-1 on Ca
2+ influx in presynaptic terminals of hippocampal neurons. (a) Fluorescence changes in
presynaptic terminals of hippocampal neurons expressing sy-GCaMP6f and VAMP-mOr2 in response to electrical stimulation. White arrows point to
transfected boutons. Top three panels show sy-GCaMP6f fluorescence: at rest (top), after 1 AP (middle) and after 100 Hz stimulation for 1 s (bottom).
The bottom panel shows VAMP-mOr2 fluorescence after 100 Hz stimulation for 1 s. Scale bar 5 mm. The pseudocolour scale is shown below the third
panel. (b) Mean example traces from the same experiment of sy-GCaMP6f fluorescence changes in response to 5 single APs from individual presynaptic
terminals of neurons co-transfected with either empty vector (black trace) or a2(3C)d-1 (blue trace). (c) Sy-GCaMP6f fluorescence changes (expressed as
% of Fmax) in response to 1 AP from boutons co-transfected with either empty vector (black filled circles) or a2(3C)d-1 (blue filled squares) (n = 7
independent experiments, *p=0.049, paired t test). (d) Mean example traces of sy-GCaMP6f fluorescence changes in response to 5 single APs from
presynaptic terminal of neurons co-transfected with either a2(3C)d-1 (blue trace) or a2(3C)d 1 + 3C-protease (red trace). (e) Sy-GCaMP6f fluorescence
changes (expressed as % of Fmax) in response to 1 AP from boutons co-transfected with either a2(3C)d-1 (blue filled squares) or a2(3C)d 1 + 3C-
protease (red open squares) (n = 8 independent experiments, ***p=0.0005, paired t test).
DOI: 10.7554/eLife.21143.022
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completely prevented by the uncleaved a2(3C)d-1, and this is reversed by its intracellular proteolytic
cleavage with the 3C protease. Thus, the proteolytic processing of a2d represents an essential check-
point for neuronal trafficking of calcium channels, to ensure that only mature channel complexes
capable of voltage-dependent activation reach specific plasma membrane domains such as presyn-
aptic terminals (Figure 7—figure supplement 1). We have shown previously that the small GTPase,
rab11, is involved in a2d-mediated trafficking of calcium channels (Tran-Van-Minh and Dolphin,
2010), and rab11, among many other proteins, is important for vesicular cargo transport into neu-
rites (Villarroel-Campos et al., 2016). We have also identified the importance of adaptor protein-1
in CaV2.2 trafficking (Macabuag and Dolphin, 2015). It will be of great interest in future studies to
determine the additional mechanisms present in neurons, in contrast to non-neuronal cell lines,
restricting the cargo transport into neurites to activatable calcium channel complexes in which a2d
subunits are proteolytically cleaved.
Materials and methods
Molecular biology
The cDNAs used were: rat a2d-1 (M86621) and mouse a2d-3 (AJ010949), rabbit CaV2.2 (D14157
without 3’ UTR), and rat b1b (Tomlinson et al., 1993). In some experiments CaV2.2 was used with an
N-terminal GFP (Macabuag and Dolphin, 2015), or containing an extracellular BBS tag or HA tag
(Cassidy et al., 2014). a2d-1-HA (HA-tag sequence YPYDVPDYA inserted between Asn-549 and
Asp-550) (Kadurin et al., 2012) and a2d-3-HA (HA between Lys-595 and Arg-596) were used in all
imaging and other experiments except when the subunits were co-expressed with CaV2.2-HA in hip-
pocampal neurons, in which case untagged a2d-1 or a2d-3 were used. Both a2d-HA constructs
showed normal function in terms of enhancing CaV currents ([Kadurin et al., 2012] and data not
shown). Proteolytic cleavage site mutations were made as indicated (1b and 4c). GFP-b1b was used
in some electrophysiological experiments (Waithe et al., 2011). Human TASK3 (KCNK9) cDNA
(NM_001282534) was obtained from Prof. A Mathie. The cDNAs were in the pMT2 vector for expres-
sion in tsA-201 cells, in pcDNA3 for expression in N2A cells and pcDNA3 or pCAGGS for expression
in DRG or hippocampal neurons, respectively. In our hands expression of the large constructs encod-
ing CaV2.2 and a2d in pcDNA3 was very poor in hippocampal neurons (data not shown), whereas
expression from the pCAGGS vector, containing chicken b-actin promoter, was strong and sus-
tained. The cDNAs encoding Human Rhinovirus (HRV) 3C protease or mutated 3C (in which the
active site Cys-147 was mutated to Val) were first subcloned into the pHLSec vector
(Yurtsever et al., 2012; Aricescu et al., 2006), using Age I and Kpn I sites in frame with an N-termi-
nal signal sequence, to include the signal sequence from pHLSec, and then into pMT2 and pCAGGS
vectors for expression in cell lines or hippocampal neurons. VAMP-mOr2 was generated by replacing
mCherry from pCAGGs-VAMPmCherry (gift from Dr. TA Ryan) with mOrange2. Sy-GCaMP6f was
made by replacing GCaMP3 in pCMV-SyGCaMP3 (gift from Dr. TA Ryan) by GCaMP6f (Chen et al.,
2013). The cDNA for mut2-GFP (Cormack et al., 1996) in pMT2 was used as a negative control in
co-immunoprecipitation (co-IP) experiments. Site-directed mutagenesis was carried out using stan-
dard procedures, and all subcloning and mutations confirmed by sequencing.
Antibodies and other materials
Ca channel antibodies (Abs) used were: a2d-1 Ab (mouse monoclonal against a2-1 moeity, Sigma-
Aldrich, epitope identified in [Cassidy et al., 2014]), a2-3 (71–90) Ab (rabbit; polyclonal)
(Davies et al., 2010), d-3 (1035–1049) Ab (Davies et al., 2010), anti-CaV2.2 II-III loop Ab (rabbit
polyclonal) (Raghib et al., 2001). Other Abs used were anti-HA (rat monoclonal, Roche), anti-HA
(rabbit polyclonal, Sigma), anti-GAPDH Ab (mouse monoclonal, Ambion), anti-flotillin-1 (mouse
monoclonal, BD Biosciences), and GFP Ab (Living Colors, rabbit polyclonal; BD Biosciences). For
immunocytochemistry, secondary Abs (1:500) used were anti-rabbit-Alexa Fluor 594, anti-rat-Alexa
Fluor 594, anti-mouse-Alexa Fluor 647 (Life Technologies) or fluorescein isothiocyanate (FITC)-anti-
rat (Sigma-Aldrich). The following secondary Abs were used for western blot: goat anti-rabbit, goat
anti-rat and goat anti-mouse Abs coupled to horseradish peroxidase (HRP) (Biorad, Hemel Hemp-
stead, UK). The signal was obtained by HRP reaction with fluorescent product (ECL 2; Thermo Scien-
tific) and membranes were scanned on a Typhoon 9410 phosphorimager (GE Healthcare).
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Lyophilized active thrombin was obtained from Sigma, suspended in filter-sterilised PBS (Sigma;
pH7.4) to 1000 U/ml and frozen in aliquots until use.
Cell culture, transfection and enzymatic treatment
Cell lines were plated onto cell culture flasks, coverslips or glass-bottomed dishes (MatTek Corpora-
tion, Ashland, MA), coated with poly-L-lysine, and cultured in a 5% CO2 incubator at 37˚C. The
human embryonic kidney tsA-201 cells (European Collection of Authenticated Cell Cultures, #
96121229), tested to be mycoplasma-free, were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (FBS), 1 unit/ml penicillin, 1 mg/ml streptomy-
cin and 1% GlutaMAX (Life Technologies, Waltham, MA). tsA-201 cells were transfected using
Fugene6 (Promega, Fitchburg, WI), according to the manufacturer’s protocol. The enzymatic treat-
ments with 30 U/ml Thrombin protease (Sigma) diluted in DMEM without supplements were done
for indicated times in a 5% CO2 incubator at 37˚C. Mouse neuroblastoma N2A cells (American Tissue
culture collection, # CCL-131) were obtained from Professor Roger Morris, Kings College London
(Parkyn et al., 2008), and were tested to be mycoplasma-free. They were cultured in 50% DMEM
and 50% OPTI-MEM supplemented with 5% FBS, 1 unit/ml penicillin, 1 mg/ml streptomycin, and 1%
GlutaMAX. N2A cells were transfected using PolyJet (SignaGen Laboratories, Gaithersburg, MD),
according to the manufacturer’s protocol.
Neuronal culture and transfection
DRG neurons were isolated from P10 male Sprague Dawley rats and transfected essentially as
described recently (D’Arco et al., 2015) with an Amaxa Nucleofector (Lonza, Basel, Switzerland)
according to the manufacturer’s protocol. Transfected neurons were plated onto coverslips coated
with poly-L-lysine, and cultured in DMEM/F12 supplemented with 10% FBS, 1 unit/ml penicillin, 1
mg/ml streptomycin, 1% GlutaMAX and 100 ng/ml NGF in a 5% CO2 incubator at 37˚C. Hippocam-
pal neurons were obtained from P0 rat pups as previously described (Morales et al., 2000). Approx-
imately 75  103 cells in 100 ml of plating solution (Neurobasal medium supplemented with B27 (Life
Technologies; 2%), HEPES (10 mM), horse serum (5%), glutamine (0.5 mM), and 1 unit/ml penicillin,
1 mg/ml streptomycin) were seeded onto sterile poly-lysine-coated glass coverslips. After 2 hr, the
plating solution was replaced with 1 ml of growth medium (serum-free Neurobasal medium supple-
mented with B27 (Life Technologies; 4%), 2-mercaptoethanol (25 mM), glutamine (0.5 mM), and 1
unit/ml penicillin, 1 mg/ml streptomycin), half of which was replaced every 3–4 days. At 7 days in
vitro (DIV) and 2 hr before transfection, half of the medium was removed, and kept as ‘conditioned’
medium and 500 ml of fresh medium was added. The hippocampal cell cultures were then trans-
fected with Lipofectamine 2000 according to the manufacturer’s protocol using 2 mg of cDNA mix
per well (Invitrogen). After 2 hr, the transfection mixes were replaced with growth medium consisting
of 50% ‘conditioned’ and 50% fresh medium. The cultures were used for immunostaining experi-
ments at 14 DIV, or for live imaging as described below.
Cell surface biotinylation, Cell lysis, deglycosylation and
immunoblotting
The procedures were modified from those described in more detail previously (Davies et al., 2010;
Page et al., 2004). Briefly, 72 hr after transfection, tsA-201 cells were incubated for 30 min at room
temperature with 0.5 mg/ml Premium Grade EZ-link Sulfo-NHS-LC-Biotin (Thermo Scientific) in PBS
and the reaction was quenched with 200 mM glycine. The cells were incubated for 45 min on ice in
PBS, pH 7.4 at 4˚C containing 1% Igepal; 0.1% SDS and protease inhibitors (PI, cOmplete, Roche;
used according to manufacturer’s instructions), to allow cell lysis. The WCL was then centrifuged at
18,000 g for 20 min at 4˚C and the pellet discarded. The supernatant was assayed for total protein
(Bradford assay, Biorad). Immunoblot analysis was performed essentially as described previously
(Kadurin et al., 2012). Cleared WCL corresponding to 20–40 mg total protein was diluted with
Laemmli sample buffer (Davies et al., 2010) supplemented with 100 mM dithiothreitol (DTT), incu-
bated at 60˚C for 10 min and resolved by SDS-polyacrylamide gel electrophoresis (PAGE) on 3%–8%
Tris-Acetate or 4–12% Bis-Tris gels (Invitrogen) and transferred to polyvinylidene fluoride (PVDF)
membrane (Biorad) by western blotting. When required the membrane was cut and incubated with
different antibodies. Biotinylated lysates (adjusted to between 0.5 and 1 mg/ml total protein
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concentration) were applied to 40 ml prewashed streptavidin-agarose beads (Thermo Scientific) and
rotated overnight at 4˚C. The beads were then washed 3 times with PBS containing 0.1% Igepal
and, when required, the streptavidin beads were re-suspended in PNGase-F buffer (PBS, pH 7.4,
supplemented with 75 mM b-mercaptoethanol, 1% Igepal, 0.1% SDS, and PI) and deglycosylated for
3 hr at 37˚C with 1 unit of PNGase-F (Roche Applied Science) added per 10 ml volume. The samples
were then resuspended in an equal volume of 2  Laemmli buffer with 100 mM DTT, followed by 10
min incubation at 60˚C. The eluted protein was analysed by immunoblotting, as described above.
GAPDH is ~39 kDa and does not resolve well in 3–8% Tris-Acetate gels. Therefore, in cases when 3–
8% gels were used to resolve high MW proteins, which required GAPDH as negative control for bio-
tinylated fractions, the same samples were re-loaded on a 4–12% Bis-Tris gel to analyse separately.
Co–immunoprecipitation
The protocol was adapted from a procedure described previously (Gurnett et al., 1997). Briefly, a
tsA-201 cell pellet derived from one confluent 75-cm2 flask was resuspended in a co-IP buffer (20
mM HEPES (pH 7.4), 300 mM NaCl, 1% Digitonin and PI), sonicated for 8 s at 20 kHz and rotated for
1 hr at 4˚C. The samples were then diluted with an equal volume of 20 mM HEPES (pH 7.4), 300 mM
NaCl with PI (to 0.5% final concentration of Digitonin), mixed by pipetting and centrifuged at 18,000
g for 20 min. The supernatants were collected and assayed for total protein (Bradford assay; Bio-
rad). 1 mg of total protein was adjusted to 2 mg/ml with co-IP buffer and incubated overnight at 4˚C
with anti-GFP polyclonal antibody (1:200; BD Biosciences). 30 ml A/G PLUS Agarose slurry (Santa
Cruz) was added to each tube and further rotated for 2 hr at 4˚C. The beads were then pelleted by
500 g centrifugation at 4˚C and washed three times with co-IP buffer containing 0.2% Digitonin.
The beads were then resuspended in an equal volume of PNGase-F buffer and proteins were degly-
cosylated with PNGase-F as described above. Aliquots of the initial WCL prior to co-IP were also
deglycosylated in parallel; 2  Laemmli buffer with 100 mM DTT was added and samples were ana-
lysed by SDS-PAGE and western blotting.
Preparation of triton X-100-insoluble membrane fractions (DRMs)
The protocol was similar to that described previously (Davies et al., 2010; Kadurin et al., 2012). All
steps were performed on ice. Confluent tsA-201 cells from two 175-cm (Kurshan et al., 2009) flasks
were taken up in Mes-buffered saline (MBS, 25 mm Mes, pH 6.5, 150 mm NaCl, and PI) containing
1% (v/v) Triton X-100 (TX-100) (Thermo Scientific), and left on ice for 1 hr. An equal volume of 90%
(w/v) sucrose in MBS was then added to a final concentration of 45% sucrose. The sample was trans-
ferred to a 13 ml ultracentrifuge tube and overlaid with 10 ml of discontinuous sucrose gradient,
consisting of 35% (w/v) sucrose in MBS (5 ml) and 5% (w/v) sucrose in MBS (5 ml). The sucrose gra-
dients were ultra-centrifuged at 140,000 gavg (Beckman SW40 rotor) for 18 hr at 4˚C. 1 ml fractions
were subsequently harvested from the top to the bottom of the tube and aliquots of 10 ml from
each fraction were analysed by SDS-PAGE and western blotting to obtain DRM profiles. When nec-
essary, DRMs (combined peak fractions identified by the presence of flotillin-1) from the gradient
were washed free of sucrose by dilution into 25 volumes of cold PBS (pH 7.4) and pelleted by ultra-
centrifugation at 150,000 g (Beckman Ti 70 rotor) for 1 hr at 4˚C. TX-100-insoluble protein was
resuspended in appropriate buffers as described for 3H-gabapentin binding or for deglycosylation
as described above.
Immunocytochemistry, imaging and analysis
The procedure in tsA-201 and N2A cells was performed essentially as described previously with
minor modifications (Davies et al., 2010; Kadurin et al., 2012). Briefly, 48 hr post-transfection the
cells were fixed with 4% paraformaldehyde (PFA) in PBS, pH7.4 at 20˚C for 5 min, and then incu-
bated for PBS for 15 min, which contained 0.1% TX-100 if permeabilization was applied. Blocking
was performed for 1 hr at 20˚C in PBS containing 20% goat serum and 5% bovine serum albumen
(BSA). The indicated primary antibodies were then applied (diluted in PBS with10% goat serum and
2.5% BSA) overnight at 4˚C or for 1 hr at 20˚C. In live-labelling experiments, cells were washed with
Krebs Ringer HEPES (KRH) buffer, labelled with a-bungarotoxin (BTX)-AF 488 (Invitrogen; 1:100 in
KRH buffer) at 17˚C for 30 min, then washed with KRH and fixed as described above. The indicated
secondary antibodies were applied (1:500 dilution in PBS, containing 2.5% BSA and 10% goat serum)
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at 20˚C for 1 hr. Cell nuclei were stained with 0.5 mM 4’,6’-diamidino-2-phenylindole (DAPI) in PBS
for 5 min. The coverslips were mounted onto glass slides using VECTASHIELD mounting medium
(Vector Laboratories, Peterborough, UK). Cultures of transfected hippocampal neurons were fixed
after 14 DIV in PBS containing 4% PFA/4% sucrose for 5 min at 20˚C, and then the procedure was as
described above. In some cases, where stated, an antigen retrieval step was performed between the
fixation and blocking steps: the cells were incubated for 10 min at 95˚C in 10 mM citrate buffer (pH
6) containing 0.05% Tween 20.
Imaging was performed on Zeiss LSM 780 confocal microscope as described in more detail else-
where (Davies et al., 2010; Kadurin et al., 2012). Images were obtained at fixed microscope set-
tings for all experimental conditions of each experiment. Images of N2A and tsA-201 cells were
obtained using a 63  objective at a resolution of 1024  1024 pixels and an optical section of 0.8–1
mm. After choosing a region of interest containing transfected cells, the 3  3 tile function of the
microscope allowed imaging of a larger area selected without bias. Every cell identified as trans-
fected was included in the measurements, to ensure lack of bias.
Images of tsA-201 and N2A cells were analyzed using imageJ (imagej.net) using a modification of
the procedure described previously (Davies et al., 2010; Kadurin et al., 2012). Surface labelling in
non-permeabilized or total staining in permeabilized cell bodies was measured using the freehand
line tool and manually tracing the surface of the cell or drawing around the cell (omitting the nucleus)
respectively. The value of the mean pixel intensity in different channels was measured separately
and background was subtracted by measuring the intensity of an imaged area without transfected
cells. All data were then normalized to the appropriate positive control for each experiment before
combining experiments.
Hippocampal neurons were imaged using a 20  objective with a 5 mm optical section. Large tiles
were manually selected following all processes expressing mCherry. The fluorescence intensity along
neuronal projections of hippocampal neurons was assessed in FIJI as follows: a circle of 100 mm
diameter was drawn around each neuronal cell body. A free-hand line (2 mm thick; ~ 30 mm long)
was drawn along the neurite extending beyond the circle and the mean grey intensity of all the pix-
els within the line was measured in both channels corresponding to the fluorescence of HA or a2d-1
immunostaining and mCherry.
Analysis of a2d-1 in dorsal root ganglion (DRG) neurons and axons
Immunoblotting of DRG tissue and associated nerves was performed as described previously
(Bauer et al., 2009). Tissue was taken from rats 4d following a spinal nerve ligation procedure, per-
formed in the course of a previous study (Bauer et al., 2009), in order to increase the amount of
a2d-1 protein in the harvested tissue. Tissue from DRGs, sections of spinal nerve and dorsal roots
were pooled from 4 rats, and stored at  80˚C until use in this study. For deglycosylation, protein
samples were diluted in PBS + 1% Igepal + 1% b-mercaptoethanol and treated with 1 unit of
PNGase F overnight at 37˚C.
3H gabapentin binding assay
Binding of 3H-gabapentin to DRM preparations was carried out, essentially as previously described
(Lana et al., 2014), in a final volume of 250 ml at room temperature for 45 min. DRM fractions (4 mg
of protein per tube) were incubated with various concentrations of [3H]-gabapentin (specific activity
36 Ci/mmol, American Radiolabeled Chemicals, St. Louis, MO, USA) in 10 mM HEPES/KOH pH 7.4,
then rapidly filtered through GF/B filters, pre-soaked with 0.3% polyethyleneimine. Filters were
washed three times with 3 ml ice-cold 50 mM Tris/HCl, pH 7.4 and counted on a scintillation counter.
Concentrations of [3H]-gabapentin greater than 50 nM were achieved by adding non-radioactive
gabapentin and correcting the specific binding by the dilution factor (Canti et al., 2005; Lana et al.,
2014). Non-specific binding was determined in the presence of 20 mM non-radioactive gabapentin.
Data points were determined in triplicate for each experiment, and data for each experiment were
analysed by fitting specific binding to the Hill equation (Lana et al., 2014).
Electrophysiology
Calcium channel currents in transfected tsA-201 cells were investigated by whole cell patch clamp
recording, essentially as described previously (Berrow et al., 1997). The patch pipette solution
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contained in mM: Cs-aspartate, 140; EGTA, 5; MgCl2, 2; CaCl2, 0.1; K2ATP, 2; Hepes, 10; pH 7.2,
310 mOsm with sucrose. The external solution for recording Ba2+ currents contained in mM: tetrae-
thylammonium (TEA) Br, 160; KCl, 3; NaHCO3, 1.0; MgCl2, 1.0; Hepes, 10; glucose, 4; BaCl2, 1,or 2
as indicated, pH 7.4, 320 mosM with sucrose. Unless otherwise stated, 1 mM extracellular Ba2+ was
the charge carrier. Pipettes of resistance 2–4 MW were used. An Axopatch 1D or Axon 200B ampli-
fier was used, and whole cell voltage-clamp recordings were sampled at 10 kHz frequency, filtered
at 2 kHz and digitized at 1 kHz. 70–80% series resistance compensation was applied and all recorded
currents were leak subtracted using P/8 protocol. For DRG neurons, whole cell voltage clamp experi-
ments were performed in small (<19 pF) and medium (20–38 pF) neurons. Membrane potential was
held at –80 mV for experiments in tsA-201 cells and  90 mV for DRG experiments. Cells were
accepted where the access resistance was less than 5 MW, the inward current was >  3 pA/pF
at +10 mV, a complete IV relationship was obtained and there was no evidence of poor voltage
clamp. Analysis was performed using Pclamp 9 (Molecular Devices) and Origin 7 (Microcal Origin,
Northampton, MA). IV relationships were fit by a modified Boltzmann equation as follows: I=Gmax*
(V Vrev)/(1+exp( (V V50, act)/k)) where I is the current density (in pA/pF), Gmax is the maximum con-
ductance (in nS/pF), Vrev is the apparent reversal potential, V50, act is the midpoint voltage for current
activation, and k is the slope factor. Recordings of resting membrane potential were performed as
previously described (Margas et al., 2016).
Live cell imaging
Hippocampal neurons were transfected with VAMP-mOr2 and sy-GCaMP6f, together with the other
cDNAs used at 7 DIV. Neurons were imaged after 14–21 DIV. Coverslips were mounted in a laminar-
flow perfusion and stimulation chamber (Warner Instruments) on the stage of an epifluorescence
microscope (Axiovert 200 M, Zeiss). White and 470 nm LEDs served as light sources (Cairn Research,
UK). Fluorescence excitation and collection was performed through a 40  1.3 NA Fluar Zeiss objec-
tive using 450/50 nm excitation and 510/50 nm emission and 480 nm dichroic filters, and a 545/25
nm excitation and 605/70 nm emission and 565 nm dichroic filters (for mOrange2). Live cell images
were acquired as previously described with minor modifications (Margas et al., 2016; Ferron et al.,
2014) with an Andor iXon+ (model DU-897U-CS0-BV) back-illuminated EMCCD camera. Fluores-
cence was collected at 100 Hz over a 512  266 pixel area (7 ms integration time). Cells were per-
fused (0.5 ml min 1) in a saline solution at 22˚C containing (in mM) 119 NaCl, 2.5 KCl, 2 CaCl2, 2
MgCl2, 25 HEPES (buffered to pH 7.4), 30 glucose, 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX) and 50 mM D,L-2-amino-5-phosphonovaleric acid (AP5). Neurons were stimulated by passing
1 ms current pulses through the field stimulation chamber via platinum electrodes. Neurons express-
ing syn-GCaMP6f were identified by stimulating the preparation at 33 Hz for 180 ms every 4 s. Sub-
sequently, single stimulations of 1 ms (mimicking a single AP) were repeated 5 times at 45 s
intervals. Functional synaptic boutons were identified by the increase of fluorescence of VAMP-
mOr2 in response to a 100 Hz stimulation for 1 s. Changes in GCaMP6f fluorescence were normal-
ized to the maximum fluorescence (Fmax) measured in the presence of 5 mM ionomycin and 2 mM
Ca2+ in the perfusion solution. Analysis was performed with ImageJ (http://rsb.info.nih.gov/ij), using
a custom-written plugin (http://rsb.info.nih.gov/ij/plugins/time-series.html). Regions of interest (ROI)
of 2 mm diameter were selected according to their responsiveness to a 100 Hz stimulation for 1 s (on
average, 20 to 100 ROIs were analyzed per field of view). Peak fluorescence in response to mean of
5 single AP stimuli was determined by averaging 5–10 points of the plateau phase and subtracting
the average of 10 points of the baseline before stimulation.
Data analysis
Data are given as mean ± SEM, or scatter plots, or box (25–75%) and whisker (10–90%) plots with
mean and median (dashed and solid lines). Statistical comparisons were performed using either Stu-
dent’s t test, paired t test, 1-sample t test, ANOVA with appropriate post-hoc test, or Krushkal-
Wallis test with appropriate post-hoc test, as stated, using Graphpad Prism 5. Details of tests are
given in Supplementary statistics file.
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